Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, witnessed a rise in share price on Monday after it disclosed a good increase in consolidated net profit for the quarter ended September 2014. During the quarter, the profit of the company rose 25.36% to Rs 772.70 million from Rs 616.40 million in the same quarter last year.

Net sales for the quarter rose 12.48% to Rs 5,470.80 million, compared with Rs 4,864 million for the prior year period.

Shares of the company are trading at Rs 403.50, up Rs 16.65, or 4.30% at the Bombay Stock Exchange (BSE) on Monday at 2:26 p.m.

The scrip has touched an intra-day high of Rs 411 and low of Rs 390. The total volume of shares traded at the BSE is 120,258.